Chemoinformaics analysis of 1,1-DIETHOXYOCTANE
| Molecular Weight | 202.338 | nRot | 10 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 0 |
| Exact Molecular Weight | 202.193 | nRing | 0 |
| Solubility: LogS | -3.863 | nHRing | 0 |
| Solubility: LogP | 4.188 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 38.9806 |
| nHD | 0 | BPOL | 29.5554 |
| QED | 0.397 |
| Synth | 2.17 |
| Natural Product Likeliness | 0.34 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.028 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.266 |
| MDCK | 0.0000273 |
| BBB | 0.243 |
| PPB | 0.938319 |
| VDSS | 1.426 |
| FU | 0.0518517 |
| CYP1A2-inh | 0.155 |
| CYP1A2-sub | 0.744 |
| CYP2c19-inh | 0.567 |
| CYP2c19-sub | 0.812 |
| CYP2c9-inh | 0.342 |
| CYP2c9-sub | 0.351 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.154 |
| CL | 10.328 |
| T12 | 0.233 |
| hERG | 0.073 |
| Ames | 0.005 |
| ROA | 0.013 |
| SkinSen | 0.534 |
| Carcinogencity | 0.081 |
| EI | 0.921 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.728469 |